Succesfuld behandling af KCNJ11-neonatal diabetes uden insulin

Birthe Gade-Rasmussen; Sten Madsbad; Maria Saur Svane; Christoffer Martinussen; Torben Hansen

Succesfuld behandling af KCNJ11-neonatal diabetes uden insulin

Birthe Gade-Rasmussen, Sten Madsbad, Maria Saur Svane, Christoffer Martinussen, Torben Hansen

Institut for Klinisk Medicin

Abstract

In this case report a 40-year-old insulin-treated male patient presented with a KCNJ11 R201H mutation, which can cause neonatal diabetes. After initiation of treatment with high doses of the sulfonylurea glibencamide in combination with the glucagon-like peptide 1 receptor agonist liraglutide, insulin treatment of the patient could be terminated. The first nine months after termination of insulin treatment the glycated haemoglobin concentration was 48-54 mmol/mol (i.e. 6.5-7.1%).

Bidragets oversatte titel	Successful treatment of KCNJ11 neonatal diabetes without insulin
Originalsprog	Dansk
Artikelnummer	V08180547
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	46
Antal sider	2
ISSN	0041-5782
Status	Udgivet - 2018

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/succesfuld-behandling-af-kcnj11-neonatal-diabetes-uden-insulin

Citationsformater

@article{c296441539db4aacb5b36d541686ae1a,

title = "Succesfuld behandling af KCNJ11-neonatal diabetes uden insulin",

abstract = "In this case report a 40-year-old insulin-treated male patient presented with a KCNJ11 R201H mutation, which can cause neonatal diabetes. After initiation of treatment with high doses of the sulfonylurea glibencamide in combination with the glucagon-like peptide 1 receptor agonist liraglutide, insulin treatment of the patient could be terminated. The first nine months after termination of insulin treatment the glycated haemoglobin concentration was 48-54 mmol/mol (i.e. 6.5-7.1%).",

author = "Birthe Gade-Rasmussen and Sten Madsbad and Svane, {Maria Saur} and Christoffer Martinussen and Torben Hansen",

year = "2018",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "46",

}

TY - JOUR

T1 - Succesfuld behandling af KCNJ11-neonatal diabetes uden insulin

AU - Gade-Rasmussen, Birthe

AU - Madsbad, Sten

AU - Svane, Maria Saur

AU - Martinussen, Christoffer

AU - Hansen, Torben

PY - 2018

Y1 - 2018

N2 - In this case report a 40-year-old insulin-treated male patient presented with a KCNJ11 R201H mutation, which can cause neonatal diabetes. After initiation of treatment with high doses of the sulfonylurea glibencamide in combination with the glucagon-like peptide 1 receptor agonist liraglutide, insulin treatment of the patient could be terminated. The first nine months after termination of insulin treatment the glycated haemoglobin concentration was 48-54 mmol/mol (i.e. 6.5-7.1%).

AB - In this case report a 40-year-old insulin-treated male patient presented with a KCNJ11 R201H mutation, which can cause neonatal diabetes. After initiation of treatment with high doses of the sulfonylurea glibencamide in combination with the glucagon-like peptide 1 receptor agonist liraglutide, insulin treatment of the patient could be terminated. The first nine months after termination of insulin treatment the glycated haemoglobin concentration was 48-54 mmol/mol (i.e. 6.5-7.1%).

M3 - Letter

C2 - 30417822

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 46

M1 - V08180547

ER -

Succesfuld behandling af KCNJ11-neonatal diabetes uden insulin

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater